Compare VCYT & AADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCYT | AADX |
|---|---|---|
| Founded | 2006 | 1900 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.3B |
| IPO Year | 2013 | 2026 |
| Metric | VCYT | AADX |
|---|---|---|
| Price | $45.91 | $9.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $58.42 | $22.88 |
| AVG Volume (30 Days) | 1.2M | ★ 1.9M |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.80 | $36.93 |
| Revenue Next Year | $10.94 | $15.57 |
| P/E Ratio | $70.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.46 | $10.31 |
| 52 Week High | $60.91 | $24.24 |
| Indicator | VCYT | AADX |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 33.00 |
| Support Level | $39.96 | N/A |
| Resistance Level | $49.46 | $13.03 |
| Average True Range (ATR) | 2.32 | 0.75 |
| MACD | 0.16 | 0.01 |
| Stochastic Oscillator | 61.84 | 6.98 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Applied Aerospace & Defense Inc specializes in providing engineering and vertically integrated manufacturing solutions for space and defense technology companies. The company builds complex hardware for extreme operating environments, combining deep material science and IP-enabled process expertise with the ability to enable rapid prototyping, enhance new product development, and responsively scale production. The majority of the company's revenue is derived from the sales of Defense Aviation and Airborne Systems, followed by Space and Launch Systems, C5ISR and Precision Strike Systems.